Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later
{{output}}
The U.S. Food and Drug Administration only gave emergency use authorization of the BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines for infants 6 months and older in June 2022. Yet questions regarding the durability of vaccine efficacy, especially against emerging v... ...
